{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:29:39Z","timestamp":1787923779636,"version":"build-2784847793"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004000","name":"Guangzhou Science and Technology Program Key Projects","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013050","name":"Guangdong Provincial Applied Science and Technology Research and Development Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014869","name":"Army Medical University Xinqiao Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014869","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.msard.2026.107347","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:08:18Z","timestamp":1782601698000},"page":"107347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Bridging to low-dose corticosteroids after satralizumab discontinuation in unplanned pregnancy: Two cases of AQP4-positive NMOSD"],"prefix":"10.1016","volume":"113","author":[{"given":"Shichun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendong","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shifeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peihao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanyan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangteng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaokai","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4004-2948","authenticated-orcid":false,"given":"Youming","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2026.107347_bib0007","article-title":"Exposure to satralizumab in AQP4-positive NMOSD during pregnancy: a case report and review of the literature","volume":"7","author":"Alonso","year":"2025","journal-title":"Neuroimmunol. Rep."},{"issue":"12","key":"10.1016\/j.msard.2026.107347_bib0003","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1212\/WNL.0b013e31824c466f","article-title":"Neuromyelitis optica and pregnancy","volume":"78","author":"Bourre","year":"2012","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.msard.2026.107347_bib0015","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1038\/s41598-025-88624-x","article-title":"Insights into neuromyelitis optica spectrum disorder and pregnancy from a single-center study in Thailand","volume":"15","author":"Budtarad","year":"2025","journal-title":"Sci. Rep."},{"issue":"Suppl 1","key":"10.1016\/j.msard.2026.107347_bib0011","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1136\/annrheumdis-2024-eular.4171","article-title":"POS0914 Glucocorticoids in pregnancy and lactation: results of the systematic review informing the EULAR task force on antirheumatic drugs in reproduction, pregnancy and lactation","volume":"83","author":"Hamroun","year":"2024","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.msard.2026.107347_bib0001","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41582-020-0313-y","article-title":"Neuromyelitis optica spectrum disorders and pregnancy: therapeutic considerations","volume":"16","author":"Mao-Draayer","year":"2020","journal-title":"Nat. Rev. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2026.107347_bib0008","article-title":"Successful childbirth during Satralizumab treatment in Neuromyelitis Optica spectrum disorder","volume":"16","author":"Nakashima","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.msard.2026.107347_bib0004","doi-asserted-by":"crossref","DOI":"10.1177\/17562864251384504","article-title":"Progress in the management of pregnancy in patients with neuromyelitis optica spectrum disorder","volume":"18","author":"Shimizu","year":"2025","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"14","key":"10.1016\/j.msard.2026.107347_bib0002","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1177\/1352458517740215","article-title":"Neuromyelitis optica spectrum disorders and pregnancy: interactions and management","volume":"23","author":"Shosha","year":"2017","journal-title":"Mult. Scler."},{"issue":"4","key":"10.1016\/j.msard.2026.107347_bib0012","doi-asserted-by":"crossref","first-page":"e1328","DOI":"10.1210\/clinem\/dgad547","article-title":"Safety of Antenatal Predniso(lo)ne and Dexamethasone on fetal, neonatal and childhood outcomes: a systematic review","volume":"109","author":"Slob","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.msard.2026.107347_bib0013","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1514687","article-title":"Case report: satralizumab as an adjunctive therapy for AQP-4 antibody and MOG antibody dual-negative optic neuritis in a third-trimester pregnancy case","volume":"11","author":"Sun","year":"2024","journal-title":"Front. Med."},{"issue":"5","key":"10.1016\/j.msard.2026.107347_bib0005","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S1474-4422(20)30078-8","article-title":"Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial","volume":"19","author":"Traboulsee","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2026.107347_bib0014","doi-asserted-by":"crossref","unstructured":"Vukusic S., Marignier R., Ciron J., Bourre B., Cohen M., Deschamps R., et al. Pregnancy and neuromyelitis optica spectrum disorders: 2022 recommendations from the French Multiple Sclerosis Society. 2023;29(1):37\u201351.","DOI":"10.1177\/13524585221130934"},{"issue":"6","key":"10.1016\/j.msard.2026.107347_bib0009","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2169\/internalmedicine.5870-25","article-title":"Safe childbirth in a patient with Neuromyelitis Optica spectrum disorder treated with Satralizumab","volume":"65","author":"Yaguchi","year":"2026","journal-title":"Intern. Med."},{"issue":"22","key":"10.1016\/j.msard.2026.107347_bib0006","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1056\/NEJMoa1901747","article-title":"Trial of Satralizumab in Neuromyelitis Optica spectrum disorder","volume":"381","author":"Yamamura","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.msard.2026.107347_bib0010","doi-asserted-by":"crossref","unstructured":"Yoshida T., Watanabe O., Nomura M., Yoshimoto Y., Maki Y., Takashima H. Neuromyelitis optica spectrum disorder safely and successfully treated with satralizumab during pregnancy and breastfeeding: a case report. 2023;Volume 14 2023.","DOI":"10.3389\/fneur.2023.1322412"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826003834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826003834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:50:08Z","timestamp":1787921408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034826003834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":15,"alternative-id":["S2211034826003834"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107347","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bridging to low-dose corticosteroids after satralizumab discontinuation in unplanned pregnancy: Two cases of AQP4-positive NMOSD","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107347","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107347"}}